Ra Capital Management, L.P. Portfolio Holdings

Ra Capital Management, L.P.

  • $7.17 Billion
  • Q3 2024

Ra Capital Management, L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $7.17 Billion distributed in 82 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.45B, Vaxcyte, Inc. with a value of $992M, Janux Therapeutics, Inc. with a value of $416M, Legend Biotech Corp with a value of $366M, and Rhythm Pharmaceuticals, Inc. with a value of $319M.

Examining the 13F form we can see an increase of $536M in the current position value, from $6.64B to 7.17B.

Ra Capital Management, L.P. is based out at Boston, MA

Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $7.17 Billion
Healthcare: $7.17 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$21.1B
$230 Million 3.2% of portfolio
1,184,456
Q3 2024 Added 20.6%

Summary

  • Portfolio
  • No. of Stocks 82
  • Current Value $7.17 Billion
  • Prior Value $6.64 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email